default author photo

Mary Beth McCarville

St. Jude Children’s Research Hospital

262 Danny Thomas Place

Memphis, TN 38105

United States

SCHOLARLY PAPERS

1

DOWNLOADS

51

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Improved Clinical Responses with the Concomitant Use of an Anti-GD2 Monoclonal Antibody During Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma: A New Treatment Paradigm

Number of pages: 31 Posted: 08 Sep 2018
St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital, St Jude Children’s Research Hospital - Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, St Jude Children’s Research Hospital - Department of Radiation Oncology, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, University of Wisconsin-Madison, Provenance Biopharmaceuticals, University of Wisconsin-Madison, Duke-NUS Graduate Medical School Singapore and St. Jude Children’s Research Hospital - Department of Oncology
Downloads 51 (1,052,702)

Abstract:

Loading...

high-risk neuroblastoma, anti-gd2, hu14.18K322A, response